GL1X · GenesisL1 explorer

MolNFT v1 · #106999 · protein

Human EPHA3 kinase domain in complex with compound 164

4TWO · Ephrin type-a receptor 3: “Human EPHA3 kinase domain in complex with compound 164”. X-ray diffraction, 1 ligand (37W), 1 pocket (best druggability 0.63). MolNFT v1 #106999 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
4TWO
Type
protein
Length
278 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ephrin type-a receptor 3
EC
2.7.10.1
UniProt
P29320
Ligands
37W
Pockets
1 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEphrin type-a receptor 3 (EC 2.7.10.1)protein27839% helix, 19% strandP29320

Ligands and binding sites

  • 37W · 5-{[3-carbamoyl-4-(3,4-dimethylphenyl)-5-methylthiophen-2-yl]amino}-5-oxopentanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12970.630.804037W

Compared structures

  • 4TWO · Human EphA3 Kinase domain in complex with compound 164 · the same entry in another collection · chain A against A, TM-score 1.00
  • P29320 · AlphaFold monomer V2.0 prediction for ephrin type-a receptor 3 (P29320) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.